Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational, Long Term Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation

NCT03611621 is registered in ClinicalTrials.gov with Hansa Biopharma AB as lead sponsor.

NCT NCT03611621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03611621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational, Long Term Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation
Lead sponsor
Hansa Biopharma AB
Phase
Observational
Overall status
Completed
Start date
June 27, 2018
Completion date
February 14, 2023
Enrollment
31 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant failure and rejection